| Syed Zulfiqar Ahmed, MD | |
|
1009 N Dixie, Elizabethtown, KY 42701 | |
| (270) 765-4361 | |
| (270) 737-7654 |
| Full Name | Syed Zulfiqar Ahmed |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 38 Years |
| Location | 1009 N Dixie, Elizabethtown, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255314407 | NPI | - | NPPES |
| 64348089 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 34808 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Intrepid Usa Healthcare Services | Elizabethtown, KY | Home health agency |
| Hardin Memorial Hospital | Elizabethtown, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthway Internal Medicine And Pediatrics Pllc | 0042483851 | 3 |
News Archive
Sarnova, Inc., the nation's leading specialty distributor of health care products in the emergency medical services (EMS) and respiratory markets, announced today that it has acquired Metropolitan Medical, Inc. Metropolitan Medical is a medical products supplier serving the mid-Atlantic region. Sarnova plans to merge Metropolitan Medical with its Tri-anim Health Services brand, which specializes in respiratory and anesthesia products for the acute care market.
Britons are missing vital weather warnings that could help reduce their risk of skin cancer. New figures show more than 70% of people questioned in a special survey do not know what the UV Index is despite its frequent appearance on TV weather forecasts and websites.
ZIOPHARM Oncology, Inc. announced today that the United States Food & Drug Administration (FDA) has granted Orphan Drug Designation to darinaparsin (Zinapar™ or ZIO-101) for the treatment of peripheral T-cell Lymphoma (PTCL). The United States Orphan Drug Act of 1983 was created to provide incentives for companies to develop and market treatments for diseases or conditions affecting fewer than 200,000 people in the United States.
BioAlliance Pharma SA, a Company dedicated to orphan oncology products and specialty products, today announces the initiation of ReLive, its phase III clinical trial with Livatag(doxorubicin Transdrug), as scheduled in the advancement calendar of the project.
Osteoarthritis is a crippling disease worldwide, with an estimated eight million sufferers in the UK alone. It has been described as like "wearing a suit of rusty armour," with unrelenting, razor-like pain.
› Verified 7 days ago
| Entity Name | Healthway Internal Medicine & Pediatrics Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881974160 PECOS PAC ID: 0042483851 Enrollment ID: O20111022000018 |
News Archive
Sarnova, Inc., the nation's leading specialty distributor of health care products in the emergency medical services (EMS) and respiratory markets, announced today that it has acquired Metropolitan Medical, Inc. Metropolitan Medical is a medical products supplier serving the mid-Atlantic region. Sarnova plans to merge Metropolitan Medical with its Tri-anim Health Services brand, which specializes in respiratory and anesthesia products for the acute care market.
Britons are missing vital weather warnings that could help reduce their risk of skin cancer. New figures show more than 70% of people questioned in a special survey do not know what the UV Index is despite its frequent appearance on TV weather forecasts and websites.
ZIOPHARM Oncology, Inc. announced today that the United States Food & Drug Administration (FDA) has granted Orphan Drug Designation to darinaparsin (Zinapar™ or ZIO-101) for the treatment of peripheral T-cell Lymphoma (PTCL). The United States Orphan Drug Act of 1983 was created to provide incentives for companies to develop and market treatments for diseases or conditions affecting fewer than 200,000 people in the United States.
BioAlliance Pharma SA, a Company dedicated to orphan oncology products and specialty products, today announces the initiation of ReLive, its phase III clinical trial with Livatag(doxorubicin Transdrug), as scheduled in the advancement calendar of the project.
Osteoarthritis is a crippling disease worldwide, with an estimated eight million sufferers in the UK alone. It has been described as like "wearing a suit of rusty armour," with unrelenting, razor-like pain.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Syed Zulfiqar Ahmed, MD 1009 N Dixie, Elizabethtown, KY 42701 Ph: (270) 765-4361 | Syed Zulfiqar Ahmed, MD 1009 N Dixie, Elizabethtown, KY 42701 Ph: (270) 765-4361 |
News Archive
Sarnova, Inc., the nation's leading specialty distributor of health care products in the emergency medical services (EMS) and respiratory markets, announced today that it has acquired Metropolitan Medical, Inc. Metropolitan Medical is a medical products supplier serving the mid-Atlantic region. Sarnova plans to merge Metropolitan Medical with its Tri-anim Health Services brand, which specializes in respiratory and anesthesia products for the acute care market.
Britons are missing vital weather warnings that could help reduce their risk of skin cancer. New figures show more than 70% of people questioned in a special survey do not know what the UV Index is despite its frequent appearance on TV weather forecasts and websites.
ZIOPHARM Oncology, Inc. announced today that the United States Food & Drug Administration (FDA) has granted Orphan Drug Designation to darinaparsin (Zinapar™ or ZIO-101) for the treatment of peripheral T-cell Lymphoma (PTCL). The United States Orphan Drug Act of 1983 was created to provide incentives for companies to develop and market treatments for diseases or conditions affecting fewer than 200,000 people in the United States.
BioAlliance Pharma SA, a Company dedicated to orphan oncology products and specialty products, today announces the initiation of ReLive, its phase III clinical trial with Livatag(doxorubicin Transdrug), as scheduled in the advancement calendar of the project.
Osteoarthritis is a crippling disease worldwide, with an estimated eight million sufferers in the UK alone. It has been described as like "wearing a suit of rusty armour," with unrelenting, razor-like pain.
› Verified 7 days ago
John A Godfrey, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 914 N Dixie Ave, Ste 304, Elizabethtown, KY 42701 Phone: 270-769-1049 Fax: 270-735-1978 | |
Dr. Charles Kenny Maffet, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 105 Diecks Dr, Elizabethtown, KY 42701 Phone: 270-737-6300 | |
Mallory Ann Doyle, AGPCNP Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 105 Financial Pl, Elizabethtown, KY 42701 Phone: 270-765-5112 | |
Mahendra M Patel, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 105 Financial Pl Ste 105, Elizabethtown, KY 42701 Phone: 270-765-5112 Fax: 270-737-9252 | |
Dr. Scott Raymond Monnin, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1324 Woodland Dr Ste A, Elizabethtown, KY 42701 Phone: 270-765-5921 Fax: 270-982-3324 | |
Mrs. Vivian H Bland, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 914 N Dixie Ave, Suite 306, Elizabethtown, KY 42701 Phone: 270-769-1559 Fax: 270-234-9152 | |
Dr. Kamal Moulana, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1240 Woodland Dr, Elizabethtown, KY 42701 Phone: 270-769-9881 Fax: 270-769-9589 |